1221-P: UK First National Health Service (NHS) Endobarrier (EB) Service for Uncontrolled Diabesity: Three-Year Outcomes for All 62 Treated Patients

Autor:	Susan P. Irwin, Mark S. Anderson, Tahira Bashir, John Bleasdale, Piya Sen Gupta, Robert E.J. Ryder, Edward Fogden, Melanie C. Wyres, Wyn Burbridge, Mahender Yadagiri
Rok vydání:	2021
Předmět:	Diabetes duration Service (business) Pediatrics medicine.medical_specialty business.industry Endocrinology Diabetes and Metabolism Internal Medicine Medicine National health service business
Zdroj:	Diabetes. 70
ISSN:	1939-327X 0012-1797
DOI:	10.2337/db21-1221-p
Popis:	EB, a 60cm endoscopically inserted proximal intestinal liner, reduces weight and HbA1c over 1 year. In the 1st NHS EB service, we provided EB to patients with sub optimally controlled diabesity and monitored outcomes in a registry. 45/62 (73%) completing 2 years post EB removal (age 51.4±7.7 years, 53% male, diabetes duration 14.4 (8-20) years, BMI 41.7±7.2 kg/m2) attended follow-up. During EB treatment, mean ± SD HbA1c fell by 1.9±1.8 %, from 9.2±1.8 to 7.3±1.0 % (p Disclosure R. E. J. Ryder: Other Relationship; Self; Novo Nordisk. E. Fogden: None. P. Sen gupta: Other Relationship; Self; Napp Pharmaceuticals. M. Yadagiri: None. W. Burbridge: None. S. P. Irwin: None. T. Bashir: None. M. C. Wyres: None. J. Bleasdale: None. M. Anderson: None.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::636a28803e97bf9f51b4890836bb9d54 https://doi.org/10.2337/db21-1221-p Zobrazit plný text záznamu